Pei Wang
Senior VP, Clinical Development & CMC Eureka Therapeutics
Seminars
Wednesday 16th September 2026
Panel Discussion: Highlighting Strategies to Streamline Regulatory Approval Across Regulatory Agencies
2:30 pm
- Detailing the transition process between FDA, EMA and IIT clinical programs to streamline clinical development across borders
- Discussing strategies for incorporating early clinical readouts from international studies to enable faster decision making before US trial initiation
- Evaluating evolving US regulatory comfort with globally generated data to showcase how aligned global development strategies can accelerate innovation while maintaining regulatory rigor
Wednesday 16th September 2026
Advancing Autologous Therapies to Enable Durable Solid Tumor Therapy
5:30 pm
- Engineering T-cells to enhance T-cell fitness and persistence within immunosuppressive tumor microenvironments
- Advancing clinical studies to bridge preclinical promise to patient impact
